This issue of Quest features an article on how the Fred Hutchinson Cancer Research Center will build from its expertise in leukemia research to have a greater impact on many other types of cancer.

The article explains why leukemia has been easier to study than other forms of cancer and how leukemia research has produced many "firsts" that apply to other cancers - the first genetic change, first adult stem-cell therapy, first immune therapy, first molecular diagnosis of different disease types, first sensitive genetic tests for early disease, and first specific molecular therapy. These advances, many of which occurred at the Hutchinson Center, will be equally important in fighting other forms of cancer.

To read on, see From the Director.